- Tiange Shi et al. Metabolomic profiles in relapsing-remitting and progressive multiple sclerosis compared to healthy controls: a five-year follow-up study. Metabolomics. 2023 Apr 20;19(5):44.
- Łukasz Rzepiński et al. Amino Acid Levels as Potential Biomarkers of Multiple Sclerosis in Elderly Patients: Preliminary Report. J Clin Neurol. 2022 Sep;18(5):529-534.
- S L Hauser et al. An antispasticity effect of threonine in multiple sclerosis. Arch Neurol. 1992 Sep;49(9):923-6.
- A Lee, V Patterson. A double-blind study of L-threonine in patients with spinal spasticity. Acta Neurol Scand. 1993 Nov;88(5):334-8.
- J H Growdon et al. L-threonine in the treatment of spasticity. Clin Neuropharmacol. 1991 Oct;14(5):403-12.
- A Barbeau, M Roy, C Chouza. Pilot study of threonine supplementation in human spasticity. Can J Neurol Sci. 1982 May;9(2):141-5.
- Enes Akyuz et al. Exploring the Role of Neurotransmitters in Multiple Sclerosis: An Expanded Review. ACS Chem Neurosci. 2023 Feb 15;14(4):527-553.